Spectra Plasmonics

Spectra Plasmonics is a specialized diagnostics and analytical instrumentation company that developed a high-performance Surface-Enhanced Raman Spectroscopy (SERS) platform. Their flagship technology, Amplifi, provides a cost-effective and highly sensitive method for detecting trace amounts of chemical substances in complex samples. The company's solutions are primarily utilized in harm reduction for drug testing, forensic analysis, and food safety monitoring. By integrating advanced nanotechnology with Raman spectroscopy, Spectra Plasmonics enables rapid, lab-grade chemical identification in field settings. In 2023, the company was acquired by Malvern Panalytical to enhance their molecular analysis portfolio.